Another major player has joined the growing list of companies embracing Bitcoin as a key financial asset.
The increasing adoption of the flagship cryptocurrency by institutions signals a shift in how businesses approach treasury management and long-term value preservation.
Biopharmaceutical firm Hoth Therapeutics has revealed plans to acquire $1 million worth of Bitcoin to strengthen its treasury reserves. The decision, approved by the company’s Board of Directors, underscores the rising confidence in Bitcoin as a reliable store of value. CEO Robb Kine highlighted Bitcoin’s inflation-resistant characteristics and its growing acceptance as a primary asset class, driven by institutional interest and the approval of Bitcoin ETFs.
This announcement comes during a wave of enthusiasm in the cryptocurrency market. Bitcoin recently hit a new all-time high of $97,400, fueled by robust inflows into ETFs and positive market sentiment following Donald Trump’s reelection. Speculation about a strategic U.S. Bitcoin reserve has further bolstered optimism. The launch of Bitcoin ETF options today has added to the excitement, with analysts anticipating strengthened market momentum.
Hoth Therapeutics’ move reflects the broader trend of corporations turning to Bitcoin to diversify their financial strategies, reinforcing its status as a cornerstone asset in the evolving financial landscape.
Swan, a Bitcoin-focused financial firm, has issued a striking market update suggesting that the current BTC cycle isn’t just another repeat of the past—it might be the last of its kind.
Ross Ulbricht, founder of the infamous Silk Road marketplace, is back in the headlines after receiving a mysterious transfer of 300 BTC—valued at roughly $31 million.
Bitcoin could be heading for a notable dip if it fails to stay above a key price zone, according to market watcher DonAlt.
A new report from Cane Island reveals a startling truth about Bitcoin’s supply: by late 2025, over 7 million BTC could be permanently lost—more than one-third of all coins ever mined.